New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
06:18 EDTMKCMcCormick Q4 miss brings buying opportunity, says Jefferies
Jefferies believes McCormick's Q4 earnings miss and lower than expected FY13 guidance creates an attractive entry point into shares. The firm thinks the company's fundamentals are intact and keeps a Buy rating on the name with a $70 price target.
News For MKC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 5, 2015
14:46 EDTMKCMcCormick management to meet with JPMorgan
Meeting to be held in Boston on October 7 hosted by JPMorgan.
October 1, 2015
09:20 EDTMKCOn The Fly: Pre-market Movers
HIGHER: XOMA (XOMA), up 55.7% after announcing an agreement for anti-TGFb program with Novartis (NVS)... Sarepta Therapeutics (SRPT), up 10.6% after announcing additional clinical efficacy and safety data from the company's Phase IIb program of eteplirsen... Huntsman (HUN), up 3.8% after announcing a $150M share repurchase program... Mellanox (MLNX), up 3.2% after raising third quarter revenue guidance. DOWN AFTER EARNINGS: McCormick (MKC), down 3.4%. ALSO LOWER: Capstone Turbine (CPST), down 26.5% after announcing that its preliminary second quarter earnings were notably below management's expectations and analysts' consensus estimates... Concho Resources (CXO), down 3.9% after 7.7M share Spot Secondary priced at $92.50... AGCO (AGCO), down 3.5% after being downgraded to Sell from Neutral at UBS.
06:38 EDTMKCMcCormick sees FY15 EPS ex-items at low end of $3.47-$3.54, consensus $3.52
Subscribe for More Information
06:35 EDTMKCMcCormick reports Q3 EPS ex-items 85c, consensus 87c
Subscribe for More Information
September 30, 2015
15:01 EDTMKCNotable companies reporting before tomorrow's open
Subscribe for More Information
September 29, 2015
06:36 EDTMKCMcCormick October volatility elevated into Q3 and outlook
McCormick October call option implied volatility is at 36, November is at 24; compared to its 52-week range of 13 to 29, suggesting large near term price movement into the expected release of Q3 results on October 1.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use